Effects of teleocidin on the morphology and c-myc expression of hepatoma cells which are not inhibited by protein kinase antagonists.

Abstract

PLC/PRF/5 hepatoma cells cultured with a tumor promoter teleocidin showed polygonal cellular appearance with many vacuole-like structures, and reduced both c-myc mRNA level and growth rate. These teleocidin effects were partly mimicked by sodium butyrate but not by a protein kinase C stimulant 1-oleoyl-2-acetylglycerol(OAG). Protein kinase C inhibitor 1-(5-isoquinolinyl-sulfonyl)-2-methyl-piperazine(H7), calmodulin-dependent protein kinase antagonist N-(6-aminohexyl)-5-chloro-1-naphthalene sulfonamide(W7) and topoisomerase II inhibitor novobiocin failed to inhibit the effects of teleocidin. These results may suggest the presence of still unknown biochemical pathways which mediate the actions of teleocidin.

• Authors: Y Kaneko, G Toda, H Oka
• Journal: Biochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 145 Issue 1 Pg. 549-55 (May 29 1987) ISSN: 0006-291X [Print] United States
• PMID: 3109417 (Publication Type: Journal Article)

Chemical References

• Butyrates
• Diglycerides
• Isoquinolines
• Lyngbya Toxins
• Piperazines
• Protein Kinase Inhibitors
• Sulfonamides
• Novobiocin
• teleocidins
• W 7
• 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
• 1-oleoyl-2-acetylglycerol

Topics

• 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
• Animals
• Butyrates (pharmacology)
• Cell Division (drug effects)
• Diglycerides (pharmacology)
• Isoquinolines (pharmacology)
• Liver (cytology, drug effects)
• Liver Neoplasms, Experimental (genetics, pathology)
• Lyngbya Toxins (pharmacology)
• Novobiocin (pharmacology)
• Piperazines (pharmacology)
• Protein Kinase Inhibitors
• Proto-Oncogenes (drug effects)
• Rats
• Sulfonamides (pharmacology)
• Transcription, Genetic (drug effects)